J&J’s Heart Deal Pumps Up Post-Breakup Prospects

Johnson & Johnson is betting that devices designed to keep patients’ hearts pumping will do something similar to its revenue growth.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.